Kamakura, Japan

Koji Takeo

This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koji Takeo. Retrieved from https://idiyas.com/inventor/koji-takeo-cmio3dns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Koji Takeo: Innovator in Pharmaceutical Chemistry

Introduction

Koji Takeo is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that promote neural function.

Latest Patents

Takeo holds a patent for a cyclic amine derivative that serves as an agent for promoting advillin function. This innovative agent includes a low molecular weight compound and is particularly useful for the treatment of axonal injury. The patent details a cyclic amine derivative, typically represented by a specific chemical formula, or a pharmacologically acceptable salt thereof as an active ingredient.

Career Highlights

Takeo is associated with Toray Industries, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical agents that can significantly impact medical treatments.

Collaborations

Throughout his career, Takeo has collaborated with notable colleagues, including Tatsuya Nishi and Kohji Shimoda. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Koji Takeo's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in advancing medical treatments. His work continues to inspire future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…